Search Results 1361-1370 of 18142 for CLL

  1. Spinal cord tumor - Doctors and departments - Mayo Clinic

    Spinal cord tumors can cause serious problems such as pain and paralysis. Find out about diagnosis and treatment.

  2. Spinal cord tumor - Doctors and departments - Mayo Clinic

    Spinal cord tumors can cause serious problems such as pain and paralysis. Find out about diagnosis and treatment.

  3. Spinal cord tumor - Doctors and departments - Mayo Clinic

    Spinal cord tumors can cause serious problems such as pain and paralysis. Find out about diagnosis and treatment.

  4. A Study to Evaluate Intracoronary CD34+ Cell Administration in Patients With Early Coronary Atherosclerosis - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of CD34+ cell intracoronary injections for treating coronary endothelial dysfunction (CED) ...

  5. Neuromuscular Intervention Targeted to Mechanisms of ACL Load in Athletes - Mayo Clinic Research

    This video provides a description of a clinical trial at Mayo Clinic recruiting patients recovering from ACL reconstructive surgery.

  6. Spinal cord tumor - Doctors and departments - Mayo Clinic

    Spinal cord tumors can cause serious problems such as pain and paralysis. Find out about diagnosis and treatment.

  7. Spinal cord tumor - Doctors and departments - Mayo Clinic

    Spinal cord tumors can cause serious problems such as pain and paralysis. Find out about diagnosis and treatment.

  8. Publications - Jerry D. Brewer, M.D., M.S. - Mayo Clinic

    Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma. Int J Dermatol. 2017 Nov; 56 (11): ...

  9. Virotherapy Clinical Trials - Mayo Clinic Research

    ... chronic lymphocytic leukemia, small lymphocytic lymphoma, or monoclonal B cell lymphocytosis. Biological therapies, such as lenalidomide, use substances ...

  10. Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer

    A phase II study to evaluate antitumor activity of oral cMET inhibitor INC280 in adult patients with EGFR wild-type, advanced non-small cell lung cancer (NSCLC) ...